CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Capstone Therapeutics Corp.  (CAPS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Capstone Therapeutics's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Total Assets Change -50.08 % -23.54 % -43.77 % -49.5 % -64.67 %
Y / Y Net Income Change -55.41 % -6.9 % -48.14 % -47.07 % -
Return On Assets (TTM) 133.5 % 146.85 % 139.86 % 141.92 % 134.43 %
Total Ranking # 33 # 32 # # 25 # 28
Seq. Total Assets Change -25.38 % -1.5 % -15.07 % -20.03 % 14.29 %
Seq. Net Income Change -4.44 % 3.85 % 2.9 % -56.34 % -


Roa Comment
Capstone Therapeutics Corp. yielded Return on Asset in I. Quarter above company average, at 133.5 %.

ROA decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 8 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 32 to 33.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 3
Sector # 9
S&P 500 # 32

Return On Assets Statistics
High Average Low
146.85 %
83.73 %
31.69 %
(Dec 31 2016)   (Dec. 30, 2012)


You need to upgrade your Flash Player
Financial Statements
Capstone Therapeutics's Equity $ -1 Millions CAPS's Balance sheet
Capstone Therapeutics's Income $ 0 Millions Quarterly CAPS's Income Statement
CAPS's Income by Division See CAPS's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CAPS's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for CAPS's Competitors
Roa for Capstone Therapeutics's Suppliers
Return On Asstes for CAPS's Customers

You may also want to know
CAPS's Roi CAPS's Inventory Turnover Ratio CAPS's Growth Rates CAPS's Dividend Comparisons
CAPS's Annual Roi CAPS's Profitability Ratios CAPS's Asset Turnover Ratio CAPS's Dividend Growth
CAPS's Roe CAPS's Valuation Ratios CAPS's Financial Strength Ratios CAPS's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2017, within Healthcare Sector ROA
Regenerx Biopharmaceuticals Inc  349.48 %
Pharmathene, Inc  219.02 %
Prophase Labs, Inc.  182.12 %
Ophthalix, Inc.  169.96 %
Steadymed Ltd.  145.38 %
International Stem Cell Corp  137.42 %
Capstone Therapeutics Corp.  133.50 %
Greenestone Healthcare Corp  127.56 %
Mannkind Corp  125.49 %
Tenax Therapeutics, Inc.  100.61 %
Neurometrix, Inc.  77.36 %
Elite Pharmaceuticals Inc  70.86 %
Apricus Biosciences, Inc.  61.49 %
Biotime Inc  59.79 %
Eagle Pharmaceuticals, Inc.  57.27 %
First Choice Healthcare Solutions, Inc.  43.68 %
Masimo Corp  43.32 %
Opiant Pharmaceuticals, Inc.  38.01 %
Pro Dex Inc  34.06 %
Supernus Pharmaceuticals Inc  34.06 %
Psychemedics Corp  32.74 %
Enzo Biochem Inc  30.82 %
United Therapeutics Corp  28.08 %
Fonar Corporation  27.43 %
Biotelemetry, Inc.  27.40 %



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com